Lixiang Xue

14PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersEnvironmental epidemiologyRespiratory diseasesCancer cell biologyMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 02, 2026
Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis.

|Jun 24, 2024
Hypoxia makes EZH2 inhibitor not easy-advances of crosstalk between HIF and EZH2.

Zhanya Huang, Yuanjun Tang, Jianlin Zhang

|Mar 25, 2024
Impacts of cryopreservation on phenotype and functionality of mononuclear cells in peripheral blood and ascites.

Jie Zhang, Zhongnan Yin, Zhaoyuan Liang

|Mar 23, 2024
EZH2 Inhibition Enhances PD-L1 Protein Stability Through USP22-Mediated Deubiquitination in Colorectal Cancer.

Jiaqi Huang, Qianqian Yin, Yuqing Wang

|Jun 22, 2023
Association between Changes in Plasma Metabolism and Clinical Outcomes of Sepsis.

Xin Li, Zhongnan Yin, Wei Yan

|Oct 30, 2022
A GRIP-1-EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a.

Yang-Liu Song, Ming-Hui Yang, Si Zhang

Pageof 3

Frequent Collaborators

2 joint publications

Xianlong Li

1 joint publications

Yan'e Liu

1 joint publications

Jie Zhang

1 joint publications

Baoshan Cao